Global And United States Gastrointestinal Stromal Tumor (GIST) Drug Market Report & Forecast 2022-2028

1 Study Coverage
1.1 Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction
1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Outlook 2017 VS 2022 VS 2028
1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in US$ Million for the Year 2017-2028
1.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume for the Year 2017-2028
1.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Outlook 2017 VS 2022 VS 2028
1.3.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in US$ Million for the Year 2017-2028
1.3.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume for the Year 2017-2028
1.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Gastrointestinal Stromal Tumor (GIST) Drug in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Gastrointestinal Stromal Tumor (GIST) Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Gastrointestinal Stromal Tumor (GIST) Drug Market Dynamics
1.5.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Trends
1.5.2 Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
1.5.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
1.5.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Segment by Type
2.1.1 Amcasertib
2.1.2 Anagrelide hydrochloride CR
2.1.3 APG-1351
2.1.4 Binimetinib
2.1.5 Others
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
2.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Type
2.3.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Segment by Application
3.1.1 Clinic
3.1.2 Hospital
3.1.3 Others
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Application
3.3.1 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Gastrointestinal Stromal Tumor (GIST) Drug Competitor Landscape by Company
4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Company
4.1.1 Top Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Ranked by Revenue (2021)
4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturer (2017-2022)
4.1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturer (2017-2022)
4.1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Manufacturer (2017-2022)
4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Concentration Ratio (CR)
4.2.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Gastrointestinal Stromal Tumor (GIST) Drug in 2021
4.2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base Distribution, Product Type
4.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
4.3.3 Date of International Manufacturers Enter into Gastrointestinal Stromal Tumor (GIST) Drug Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Company
4.5.1 Top Gastrointestinal Stromal Tumor (GIST) Drug Players in United States, Ranked by Revenue (2021)
4.5.2 United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Gastrointestinal Stromal Tumor (GIST) Drug Sales by Players (2020, 2021 & 2022)
5 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region
5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size in Volume by Region (2017-2028)
5.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Region: 2017-2022
5.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume Forecast by Region (2023-2028)
5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size in Value by Region (2017-2028)
5.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Region: 2017-2022
5.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth 2017-2028
6.1.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth 2017-2028
6.3.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth 2017-2028
6.4.2 Latin America Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Ariad Pharmaceuticals, Inc.
7.1.1 Ariad Pharmaceuticals, Inc. Corporation Information
7.1.2 Ariad Pharmaceuticals, Inc. Description and Business Overview
7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.1.5 Ariad Pharmaceuticals, Inc. Recent Development
7.2 Arog Pharmaceuticals, Inc.
7.2.1 Arog Pharmaceuticals, Inc. Corporation Information
7.2.2 Arog Pharmaceuticals, Inc. Description and Business Overview
7.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.2.5 Arog Pharmaceuticals, Inc. Recent Development
7.3 Array BioPharma Inc.
7.3.1 Array BioPharma Inc. Corporation Information
7.3.2 Array BioPharma Inc. Description and Business Overview
7.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.3.5 Array BioPharma Inc. Recent Development
7.4 Astex Pharmaceuticals, Inc.
7.4.1 Astex Pharmaceuticals, Inc. Corporation Information
7.4.2 Astex Pharmaceuticals, Inc. Description and Business Overview
7.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.4.5 Astex Pharmaceuticals, Inc. Recent Development
7.5 Blueprint Medicines Corporation
7.5.1 Blueprint Medicines Corporation Corporation Information
7.5.2 Blueprint Medicines Corporation Description and Business Overview
7.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.5.5 Blueprint Medicines Corporation Recent Development
7.6 Boston Biomedical, Inc.
7.6.1 Boston Biomedical, Inc. Corporation Information
7.6.2 Boston Biomedical, Inc. Description and Business Overview
7.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.6.5 Boston Biomedical, Inc. Recent Development
7.7 Calithera Biosciences, Inc.
7.7.1 Calithera Biosciences, Inc. Corporation Information
7.7.2 Calithera Biosciences, Inc. Description and Business Overview
7.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.7.5 Calithera Biosciences, Inc. Recent Development
7.8 Chipscreen Biosciences Ltd
7.8.1 Chipscreen Biosciences Ltd Corporation Information
7.8.2 Chipscreen Biosciences Ltd Description and Business Overview
7.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.8.5 Chipscreen Biosciences Ltd Recent Development
7.9 Deciphera Pharmaceuticals, LLC
7.9.1 Deciphera Pharmaceuticals, LLC Corporation Information
7.9.2 Deciphera Pharmaceuticals, LLC Description and Business Overview
7.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.9.5 Deciphera Pharmaceuticals, LLC Recent Development
7.10 F. Hoffmann-La Roche Ltd.
7.10.1 F. Hoffmann-La Roche Ltd. Corporation Information
7.10.2 F. Hoffmann-La Roche Ltd. Description and Business Overview
7.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.10.5 F. Hoffmann-La Roche Ltd. Recent Development
7.11 Horizon Pharma Plc
7.11.1 Horizon Pharma Plc Corporation Information
7.11.2 Horizon Pharma Plc Description and Business Overview
7.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
7.11.5 Horizon Pharma Plc Recent Development
7.12 Immunicum AB
7.12.1 Immunicum AB Corporation Information
7.12.2 Immunicum AB Description and Business Overview
7.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Immunicum AB Products Offered
7.12.5 Immunicum AB Recent Development
7.13 Jiangsu Hengrui Medicine Co., Ltd.
7.13.1 Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
7.13.2 Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview
7.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Jiangsu Hengrui Medicine Co., Ltd. Products Offered
7.13.5 Jiangsu Hengrui Medicine Co., Ltd. Recent Development
7.14 Kolltan Pharmaceuticals, Inc.
7.14.1 Kolltan Pharmaceuticals, Inc. Corporation Information
7.14.2 Kolltan Pharmaceuticals, Inc. Description and Business Overview
7.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Kolltan Pharmaceuticals, Inc. Products Offered
7.14.5 Kolltan Pharmaceuticals, Inc. Recent Development
7.15 Natco Pharma Limited
7.15.1 Natco Pharma Limited Corporation Information
7.15.2 Natco Pharma Limited Description and Business Overview
7.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Natco Pharma Limited Products Offered
7.15.5 Natco Pharma Limited Recent Development
7.16 Nerviano Medical Sciences S.r.l.
7.16.1 Nerviano Medical Sciences S.r.l. Corporation Information
7.16.2 Nerviano Medical Sciences S.r.l. Description and Business Overview
7.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Nerviano Medical Sciences S.r.l. Products Offered
7.16.5 Nerviano Medical Sciences S.r.l. Recent Development
7.17 Novartis AG
7.17.1 Novartis AG Corporation Information
7.17.2 Novartis AG Description and Business Overview
7.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.17.4 Novartis AG Products Offered
7.17.5 Novartis AG Recent Development
7.18 Omeros Corporation
7.18.1 Omeros Corporation Corporation Information
7.18.2 Omeros Corporation Description and Business Overview
7.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue and Gross Margin (2017-2022)
7.18.4 Omeros Corporation Products Offered
7.18.5 Omeros Corporation Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Chain Analysis
8.2 Gastrointestinal Stromal Tumor (GIST) Drug Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
8.3 Gastrointestinal Stromal Tumor (GIST) Drug Production Mode & Process
8.4 Gastrointestinal Stromal Tumor (GIST) Drug Sales and Marketing
8.4.1 Gastrointestinal Stromal Tumor (GIST) Drug Sales Channels
8.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
8.5 Gastrointestinal Stromal Tumor (GIST) Drug Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

List of Tables
Table 1. Gastrointestinal Stromal Tumor (GIST) Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Gastrointestinal Stromal Tumor (GIST) Drug Market Trends
Table 3. Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers
Table 4. Gastrointestinal Stromal Tumor (GIST) Drug Market Challenges
Table 5. Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints
Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturer, 2017-2022
Table 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Manufacturer, 2017-2022
Table 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Gastrointestinal Stromal Tumor (GIST) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Stromal Tumor (GIST) Drug as of 2021)
Table 18. Top Players of Gastrointestinal Stromal Tumor (GIST) Drug in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
Table 20. Date of International Manufacturers Enter into Gastrointestinal Stromal Tumor (GIST) Drug Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Gastrointestinal Stromal Tumor (GIST) Drug Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Ariad Pharmaceuticals, Inc. Corporation Information
Table 43. Ariad Pharmaceuticals, Inc. Description and Business Overview
Table 44. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product
Table 46. Ariad Pharmaceuticals, Inc. Recent Development
Table 47. Arog Pharmaceuticals, Inc. Corporation Information
Table 48. Arog Pharmaceuticals, Inc. Description and Business Overview
Table 49. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. Arog Pharmaceuticals, Inc. Product
Table 51. Arog Pharmaceuticals, Inc. Recent Development
Table 52. Array BioPharma Inc. Corporation Information
Table 53. Array BioPharma Inc. Description and Business Overview
Table 54. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Array BioPharma Inc. Product
Table 56. Array BioPharma Inc. Recent Development
Table 57. Astex Pharmaceuticals, Inc. Corporation Information
Table 58. Astex Pharmaceuticals, Inc. Description and Business Overview
Table 59. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Astex Pharmaceuticals, Inc. Product
Table 61. Astex Pharmaceuticals, Inc. Recent Development
Table 62. Blueprint Medicines Corporation Corporation Information
Table 63. Blueprint Medicines Corporation Description and Business Overview
Table 64. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. Blueprint Medicines Corporation Product
Table 66. Blueprint Medicines Corporation Recent Development
Table 67. Boston Biomedical, Inc. Corporation Information
Table 68. Boston Biomedical, Inc. Description and Business Overview
Table 69. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Boston Biomedical, Inc. Product
Table 71. Boston Biomedical, Inc. Recent Development
Table 72. Calithera Biosciences, Inc. Corporation Information
Table 73. Calithera Biosciences, Inc. Description and Business Overview
Table 74. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Calithera Biosciences, Inc. Product
Table 76. Calithera Biosciences, Inc. Recent Development
Table 77. Chipscreen Biosciences Ltd Corporation Information
Table 78. Chipscreen Biosciences Ltd Description and Business Overview
Table 79. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Chipscreen Biosciences Ltd Product
Table 81. Chipscreen Biosciences Ltd Recent Development
Table 82. Deciphera Pharmaceuticals, LLC Corporation Information
Table 83. Deciphera Pharmaceuticals, LLC Description and Business Overview
Table 84. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Deciphera Pharmaceuticals, LLC Product
Table 86. Deciphera Pharmaceuticals, LLC Recent Development
Table 87. F. Hoffmann-La Roche Ltd. Corporation Information
Table 88. F. Hoffmann-La Roche Ltd. Description and Business Overview
Table 89. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. F. Hoffmann-La Roche Ltd. Product
Table 91. F. Hoffmann-La Roche Ltd. Recent Development
Table 92. Horizon Pharma Plc Corporation Information
Table 93. Horizon Pharma Plc Description and Business Overview
Table 94. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. Horizon Pharma Plc Product
Table 96. Horizon Pharma Plc Recent Development
Table 97. Immunicum AB Corporation Information
Table 98. Immunicum AB Description and Business Overview
Table 99. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. Immunicum AB Product
Table 101. Immunicum AB Recent Development
Table 102. Jiangsu Hengrui Medicine Co., Ltd. Corporation Information
Table 103. Jiangsu Hengrui Medicine Co., Ltd. Description and Business Overview
Table 104. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Jiangsu Hengrui Medicine Co., Ltd. Product
Table 106. Jiangsu Hengrui Medicine Co., Ltd. Recent Development
Table 107. Kolltan Pharmaceuticals, Inc. Corporation Information
Table 108. Kolltan Pharmaceuticals, Inc. Description and Business Overview
Table 109. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Kolltan Pharmaceuticals, Inc. Product
Table 111. Kolltan Pharmaceuticals, Inc. Recent Development
Table 112. Natco Pharma Limited Corporation Information
Table 113. Natco Pharma Limited Description and Business Overview
Table 114. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Natco Pharma Limited Product
Table 116. Natco Pharma Limited Recent Development
Table 117. Nerviano Medical Sciences S.r.l. Corporation Information
Table 118. Nerviano Medical Sciences S.r.l. Description and Business Overview
Table 119. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Nerviano Medical Sciences S.r.l. Product
Table 121. Nerviano Medical Sciences S.r.l. Recent Development
Table 122. Novartis AG Corporation Information
Table 123. Novartis AG Description and Business Overview
Table 124. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 125. Novartis AG Product
Table 126. Novartis AG Recent Development
Table 127. Omeros Corporation Corporation Information
Table 128. Omeros Corporation Description and Business Overview
Table 129. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 130. Omeros Corporation Product
Table 131. Omeros Corporation Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Gastrointestinal Stromal Tumor (GIST) Drug Customers List
Table 135. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Gastrointestinal Stromal Tumor (GIST) Drug Product Picture
Figure 2. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size 2017-2028 (US$ Million)
Figure 4. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2028 (K Pcs)
Figure 5. United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Gastrointestinal Stromal Tumor (GIST) Drug Market Size 2017-2028 (US$ Million)
Figure 7. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2028 (K Pcs)
Figure 8. United States Gastrointestinal Stromal Tumor (GIST) Drug Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Gastrointestinal Stromal Tumor (GIST) Drug Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Gastrointestinal Stromal Tumor (GIST) Drug Report Years Considered
Figure 11. Product Picture of Amcasertib
Figure 12. Product Picture of Anagrelide hydrochloride CR
Figure 13. Product Picture of APG-1351
Figure 14. Product Picture of Binimetinib
Figure 15. Product Picture of Others
Figure 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type in 2022 & 2028
Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 18. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type (2017-2028)
Figure 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2028) & (K Pcs)
Figure 20. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type (2017-2028)
Figure 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 22. United States Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Type in 2022 & 2028
Figure 23. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Type (2017-2028) & (US$ Million)
Figure 24. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Type (2017-2028)
Figure 25. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2028) & (K Pcs)
Figure 26. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Type (2017-2028)
Figure 27. United States Gastrointestinal Stromal Tumor (GIST) Drug Price by Type (2017-2028) & (USD/Pcs)
Figure 28. Product Picture of Clinic
Figure 29. Product Picture of Hospital
Figure 30. Product Picture of Others
Figure 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application in 2022 & 2028
Figure 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application (2017-2028)
Figure 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2028) & (K Pcs)
Figure 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application (2017-2028)
Figure 36. Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 37. United States Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application in 2022 & 2028
Figure 38. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value by Application (2017-2028) & (US$ Million)
Figure 39. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Value by Application (2017-2028)
Figure 40. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2028) & (K Pcs)
Figure 41. United States Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share in Volume by Application (2017-2028)
Figure 42. United States Gastrointestinal Stromal Tumor (GIST) Drug Price by Application (2017-2028) & (USD/Pcs)
Figure 43. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 44. North America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 45. U.S. Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Canada Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 47. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 48. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 49. Germany Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. France Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. U.K. Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Italy Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Russia Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 54. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 55. Asia-Pacific Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 56. China Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. Japan Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. India Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Australia Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Taiwan Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Indonesia Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Thailand Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Malaysia Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Philippines Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 66. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 67. Latin America Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 68. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 71. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 72. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 73. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. UAE Gastrointestinal Stromal Tumor (GIST) Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 76. Gastrointestinal Stromal Tumor (GIST) Drug Value Chain
Figure 77. Gastrointestinal Stromal Tumor (GIST) Drug Production Process
Figure 78. Channels of Distribution
Figure 79. Distributors Profiles
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.